Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
NA-941 by Biomed Industries for Metabolic Dysfunction-Associated Steatohepatitis (MASH): Likelihood of Approval
NA-941 is under clinical development by Biomed Industries and currently in Phase III for Metabolic Dysfunction-Associated Steatohepatitis (MASH). According to...